These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 11478391

  • 21. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T, Clish CB, Gronert K, Petasis N, Serhan CN.
    J Clin Invest; 1998 Feb 15; 101(4):819-26. PubMed ID: 9466977
    [Abstract] [Full Text] [Related]

  • 22. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
    Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN.
    J Immunol; 2003 Mar 01; 170(5):2688-94. PubMed ID: 12594298
    [Abstract] [Full Text] [Related]

  • 23. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K, Kuna P.
    Pol Merkur Lekarski; 2005 May 01; 18(107):491-5. PubMed ID: 16161940
    [Abstract] [Full Text] [Related]

  • 24. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.
    Clària J, Lee MH, Serhan CN.
    Mol Med; 1996 Sep 01; 2(5):583-96. PubMed ID: 8898374
    [Abstract] [Full Text] [Related]

  • 25. Potential vascular roles for lipoxins in the "stop programs" of host defense and inflammation.
    Brady HR, Papayianni A, Serhan CN.
    Trends Cardiovasc Med; 1995 Sep 01; 5(5):186-92. PubMed ID: 21232258
    [Abstract] [Full Text] [Related]

  • 26. Lipoxins: endogenous regulators of inflammation.
    McMahon B, Godson C.
    Am J Physiol Renal Physiol; 2004 Feb 01; 286(2):F189-201. PubMed ID: 14707005
    [Abstract] [Full Text] [Related]

  • 27. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.
    Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G, Petasis NA, Erwig L, Rees AJ, Savill J, Brady HR, Godson C.
    J Am Soc Nephrol; 2002 Oct 01; 13(10):2497-507. PubMed ID: 12239238
    [Abstract] [Full Text] [Related]

  • 28. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN.
    Pharmacol Ther; 2005 Jan 01; 105(1):7-21. PubMed ID: 15626453
    [Abstract] [Full Text] [Related]

  • 29. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG, Khreiss T, József L.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jan 01; 73(3-4):257-62. PubMed ID: 15979865
    [Abstract] [Full Text] [Related]

  • 30. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C.
    Pharmacol Rev; 2006 Sep 01; 58(3):463-87. PubMed ID: 16968948
    [Abstract] [Full Text] [Related]

  • 31. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions.
    Serhan CN, Clish CB, Brannon J, Colgan SP, Gronert K, Chiang N.
    J Physiol Pharmacol; 2000 Dec 01; 51(4 Pt 1):643-54. PubMed ID: 11192938
    [Abstract] [Full Text] [Related]

  • 32. Angiogenesis and lipoxins.
    Fierro IM.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Dec 01; 73(3-4):271-5. PubMed ID: 15982864
    [Abstract] [Full Text] [Related]

  • 33. Liver: the formation and actions of aspirin-triggered lipoxins.
    Clària J, Planagumà A.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Dec 01; 73(3-4):277-82. PubMed ID: 16006110
    [Abstract] [Full Text] [Related]

  • 34. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.
    Romano M, Cianci E, Simiele F, Recchiuti A.
    Eur J Pharmacol; 2015 Aug 05; 760():49-63. PubMed ID: 25895638
    [Abstract] [Full Text] [Related]

  • 35. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
    Fierro IM, Serhan CN.
    Braz J Med Biol Res; 2001 May 05; 34(5):555-66. PubMed ID: 11323741
    [Abstract] [Full Text] [Related]

  • 36. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells.
    Ariel A, Chiang N, Arita M, Petasis NA, Serhan CN.
    J Immunol; 2003 Jun 15; 170(12):6266-72. PubMed ID: 12794159
    [Abstract] [Full Text] [Related]

  • 37. Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins.
    Romano M.
    Inflamm Allergy Drug Targets; 2006 Apr 15; 5(2):81-90. PubMed ID: 16613567
    [Abstract] [Full Text] [Related]

  • 38. Lipoxins: update and impact of endogenous pro-resolution lipid mediators.
    O'Meara SJ, Rodgers K, Godson C.
    Rev Physiol Biochem Pharmacol; 2008 Apr 15; 160():47-70. PubMed ID: 18481030
    [Abstract] [Full Text] [Related]

  • 39. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.
    Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN.
    J Exp Med; 1997 May 05; 185(9):1693-704. PubMed ID: 9151906
    [Abstract] [Full Text] [Related]

  • 40. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators.
    Wada K, Qiu FH, Stahl GL, Serhan CN.
    J Hematother Stem Cell Res; 2001 Feb 05; 10(1):75-9. PubMed ID: 11276361
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.